Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 8826 - 8850 of 12007 in total

N-[(2R)-2-{[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl}hexyl]-N-hydroxyformamide

Experimental
Matched Iupac: … N-[(2R)-3-[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]-2-butyl-3-oxopropyl]-N-hydroxyformamide …

Ethyl methoxycinnamate

Experimental
Matched Synonyms: … Ethyl (E)-4-methoxycinnamate …
Matched Iupac: … ethyl (2E)-3-(4-methoxyphenyl)prop-2-enoate …

Fenprostalene

Vet approved
Matched Iupac: … methyl 7-[(1S,2S,3S,5R)-3,5-dihydroxy-2-[(3S)-3-hydroxy-4-phenoxybut-1-en-1-yl]cyclopentyl]hepta-4,5- …

Vinylbital

Experimental

beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranose

Experimental
Matched Synonyms: … β-D-Galp-(1→4)-β-D-Galp ... 4-O-β-D-galactopyranosyl-β-D-galactopyranose ... β-D-galactopyranosyl-(1→4)-β-D-galactopyranose …
Matched Name: … beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranose …
Matched Iupac: … (2R,3R,4R,5R,6R)-6-(hydroxymethyl)-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy …

Fepixnebart

Fepixnebart is under investigation in clinical trial NCT04456686 (Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Osteoarthritis).
Investigational

4-oxo-nicotinamide-adenine dinucleotide phosphate

Experimental
Matched Name: … 4-oxo-nicotinamide-adenine dinucleotide phosphate …
Matched Iupac: … (3S)-1-[(2R,3R,4S,5R)-5-[({[({[(2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxy-4-(phosphonooxy)oxolan ... -4-oxo-3,4-dihydro-1lambda5-pyridin-1-ylium ... -2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl …

THR-184

THR-184 is under investigation in clinical trial NCT01830920 (A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-acute Kidney Injury (CSA-AKI)).
Investigational

Liprotamase protease

Experimental
Matched Synonyms: … Protease-S ... Seaprose-S …

Lintuzumab satetraxetan AC-225

Lintuzumab actinium Ac-225 is under investigation in clinical trial NCT00672165 (Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies).
Investigational

N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide

Experimental
Matched Name: … N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide …
Matched Iupac: … N-(4-phenoxyphenyl)-2-{[(pyridin-4-yl)methyl]amino}pyridine-3-carboxamide …

5-monophosphate-9-beta-D-ribofuranosyl xanthine

Experimental
Matched Iupac: … 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-9lambda5 …

Adenylosuccinic acid

Experimental
Matched Iupac: … (2S)-2-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-9H-purin-6-yl}amino)butanedioic …

ABX-196

ABX-196 is under investigation in clinical trial NCT03897543 (ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma).
Investigational
Matched Iupac: … N-[(2S,3S,4R)-1-{[(2S,3R,4S,5R,6R)-6-(acetamidomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,4-dihydroxyoctadecan …

Alsterpaullone

Experimental

N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE

Experimental

Roquinimex

Roquinimex is a derivative of quinoline that presents immunostimulant properties. Its effects are suggested to increase the activity of NK cells and macrophage cytotoxicity. Additionally, roquinimex is known to inhibit angiogenesis and to decrease the synthesis of TNF alpha.
Investigational
Matched Iupac: … 4-hydroxy-N,1-dimethyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide …

Vinpocetine

Vinpocetine has been investigated for the treatment of Epilepsy.
Investigational

Anhydrovinblastine

Anhydrovinblastine has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Matched Iupac: … methyl (1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-12-ethyl-4-[(1R,13S,15R)-17-ethyl-13-(methoxycarbonyl)- ... 1,11-diazatetracyclo[13.3.1.0^{4,12}.0^{5,10}]nonadeca-4(12),5,7,9,16-pentaen-13-yl]-10-hydroxy-5-methoxy …

Tempol

Tempol has been used in trials studying the treatment of Anal Cancer.
Investigational
Matched Synonyms: … 4-OXYPIPERIDOL ... 2,2,6,6-TETRAMETHYL-4-HYDROXYPIPERIDINOOXY ... 1-PIPERIDINYLOXY,4-HYDROXY-2,2,6,6-TETRAMETHYL- …
Matched Iupac: … (4-hydroxy-2,2,6,6-tetramethylpiperidin-1-yl)oxidanyl …

Squaric acid dibutyl ester

Squaric acid dibutyl ester is under investigation in clinical trial NCT01971385 (Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis).
Investigational
Matched Iupac: … dibutoxycyclobut-3-ene-1,2-dione …

Tyroserleutide

Investigational
Matched Iupac: … (2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-hydroxypropanamido]-4-methylpentanoic …

2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose

Experimental
Matched Iupac: … {[hydroxy({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phosphoryl]oxy}({[(2R,3S ... ,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphinic …

FINLAY-FR-1

FINLAY-FR-1, also known as Soberana 01, is a vaccine candidate for COVID-19 that is being led developmentally by the Finlay Vaccine Institute . It is currently being tested in the clinical trial RPCEC00000332 (Phase I / II, randomized, controlled, adaptive, double-blind and multicenter study to evaluate the safety, reactogenicity and...
Investigational

2-heptyl-4-hydroxyquinoline N-oxide

Experimental
Matched Synonyms: … 2-heptyl-4-quinolinol 1-oxide ... 2-heptyl-4-hydroxyquinoline N-oxide ... 2-heptyl-4-hydroxyquinoline-N-oxide …
Matched Name: … 2-heptyl-4-hydroxyquinoline N-oxide …
Matched Iupac: … 2-heptyl-4-hydroxyquinolin-1-ium-1-olate …
Displaying drugs 8826 - 8850 of 12007 in total